Joan Maurel
Research group
- Translational genomics and targeted therapies in solid tumours Accredited researcher (R3A)
Featured publications
-
Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD1402 Trial
Authors:Reference: Clinical Cancer Research 2021. -
Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study
Authors:Reference: Annals Of Oncology 2021. -
Lessons to Learn for Adequate Targeted Therapy Development in Metastatic Colorectal Cancer Patients
Authors:Reference: International Journal Of Molecular Sciences 2021. -
SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)
Authors:Reference: Clinical & Translational Oncology 2021. -
Are Quality of Randomized Clinical Trials and ESMO-Magnitude of Clinical Benefit Scale Two Sides of the Same Coin, to Grade Recommendations for Drug Approval?
Authors:Reference: Journal Of Clinical Medicine 2021. -
VITAL phase 2 study: Upfront 5-fluorouracil, mitomycin-C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09-02)
Authors:Reference: Cancer Medicine 2020. -
MET inhibitors in cancer: pitfalls and challenges
Authors:Reference: Expert Opinion On Investigational Drugs 2020. -
The Tumor Microenvironment in Colorectal Cancer Therapy
Authors:Reference: Cancers 2019. -
RAC1b overexpression correlates with poor prognosis in KRAS/BRAF WT metastatic colorectal cancer patients treated with first-line FOLFOX/XELOX chemotherapy
Authors:Reference: European Journal Of Cancer 2014. -
Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer
Authors:Reference: Endocrine-Related Cancer 2009.